Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment
- Autores
- Miceli, Diego Daniel; Zelarayán, Gabriela S; García, Jorge D; Fernández, Viviana; Ferraris, Sergio
- Año de publicación
- 2021
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- A 7-year-old spayed female domestic shorthair cat weighing 5kg was referred with polyuria, polydipsia, lethargy, abdominal distension and dermatologic abnormalities. Diabetes mellitus was diagnosed and treatment was started with a diet for diabetic cats and insulin glargine (1IU q12h SC). Hyperadrenocorticism (HAC) was suspected and diagnosed based on clinical signs, increased urinary cortisol:creatinine ratio, lack of suppression on low-dose dexamethasone suppression test and abdominal ultrasonography demonstrating bilateral adrenal enlargement. Oral cabergoline (10μg/kg every other day) was initiated. After the second administration of cabergoline, the cat suffered from clinical hypoglycemia and no longer required insulin. One month after insulin withdrawal, blood work and urine analysis results showed normoglycemia, a normal serum fructosamine concentration (244μmol/l) and normal urine analysis without glycosuria. Diabetic remission persisted until its death 7 months later. In addition, cabergoline treatment was associated with improvement in clinical signs such as lethargy, seborrhea, alopecia and abdominal distension.
Fil: Miceli, Diego Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; Argentina. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina
Fil: Zelarayán, Gabriela S. Veterinaria Paraná; Argentina
Fil: García, Jorge D. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; Argentina
Fil: Fernández, Viviana. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina
Fil: Ferraris, Sergio. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina - Materia
-
DIABETES MELLITUS REMISSION
FELINE CUSHING SYNDROME
CABERGOLINE
PITUITARY-DEPENDENT HYPERADRECORTICISM - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/140791
Ver los metadatos del registro completo
id |
CONICETDig_8fde61afe4b7e1f7a84258684126c21e |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/140791 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatmentMiceli, Diego DanielZelarayán, Gabriela SGarcía, Jorge DFernández, VivianaFerraris, SergioDIABETES MELLITUS REMISSIONFELINE CUSHING SYNDROMECABERGOLINEPITUITARY-DEPENDENT HYPERADRECORTICISMhttps://purl.org/becyt/ford/4.3https://purl.org/becyt/ford/4A 7-year-old spayed female domestic shorthair cat weighing 5kg was referred with polyuria, polydipsia, lethargy, abdominal distension and dermatologic abnormalities. Diabetes mellitus was diagnosed and treatment was started with a diet for diabetic cats and insulin glargine (1IU q12h SC). Hyperadrenocorticism (HAC) was suspected and diagnosed based on clinical signs, increased urinary cortisol:creatinine ratio, lack of suppression on low-dose dexamethasone suppression test and abdominal ultrasonography demonstrating bilateral adrenal enlargement. Oral cabergoline (10μg/kg every other day) was initiated. After the second administration of cabergoline, the cat suffered from clinical hypoglycemia and no longer required insulin. One month after insulin withdrawal, blood work and urine analysis results showed normoglycemia, a normal serum fructosamine concentration (244μmol/l) and normal urine analysis without glycosuria. Diabetic remission persisted until its death 7 months later. In addition, cabergoline treatment was associated with improvement in clinical signs such as lethargy, seborrhea, alopecia and abdominal distension.Fil: Miceli, Diego Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; Argentina. Universidad Maimónides. Centro de Ciencias Veterinarias; ArgentinaFil: Zelarayán, Gabriela S. Veterinaria Paraná; ArgentinaFil: García, Jorge D. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; ArgentinaFil: Fernández, Viviana. Universidad Maimónides. Centro de Ciencias Veterinarias; ArgentinaFil: Ferraris, Sergio. Universidad Maimónides. Centro de Ciencias Veterinarias; ArgentinaSAGE Publications2021-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/140791Miceli, Diego Daniel; Zelarayán, Gabriela S; García, Jorge D; Fernández, Viviana; Ferraris, Sergio; Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment; SAGE Publications; Journal of Feline Medicine and Surgery Open Reports; 7; 2; 6-2021; 1-72055-11692055-1169CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/20551169211029896info:eu-repo/semantics/altIdentifier/doi/10.1177/20551169211029896info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:53:26Zoai:ri.conicet.gov.ar:11336/140791instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:53:26.578CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
title |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
spellingShingle |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment Miceli, Diego Daniel DIABETES MELLITUS REMISSION FELINE CUSHING SYNDROME CABERGOLINE PITUITARY-DEPENDENT HYPERADRECORTICISM |
title_short |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
title_full |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
title_fullStr |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
title_full_unstemmed |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
title_sort |
Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment |
dc.creator.none.fl_str_mv |
Miceli, Diego Daniel Zelarayán, Gabriela S García, Jorge D Fernández, Viviana Ferraris, Sergio |
author |
Miceli, Diego Daniel |
author_facet |
Miceli, Diego Daniel Zelarayán, Gabriela S García, Jorge D Fernández, Viviana Ferraris, Sergio |
author_role |
author |
author2 |
Zelarayán, Gabriela S García, Jorge D Fernández, Viviana Ferraris, Sergio |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
DIABETES MELLITUS REMISSION FELINE CUSHING SYNDROME CABERGOLINE PITUITARY-DEPENDENT HYPERADRECORTICISM |
topic |
DIABETES MELLITUS REMISSION FELINE CUSHING SYNDROME CABERGOLINE PITUITARY-DEPENDENT HYPERADRECORTICISM |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/4.3 https://purl.org/becyt/ford/4 |
dc.description.none.fl_txt_mv |
A 7-year-old spayed female domestic shorthair cat weighing 5kg was referred with polyuria, polydipsia, lethargy, abdominal distension and dermatologic abnormalities. Diabetes mellitus was diagnosed and treatment was started with a diet for diabetic cats and insulin glargine (1IU q12h SC). Hyperadrenocorticism (HAC) was suspected and diagnosed based on clinical signs, increased urinary cortisol:creatinine ratio, lack of suppression on low-dose dexamethasone suppression test and abdominal ultrasonography demonstrating bilateral adrenal enlargement. Oral cabergoline (10μg/kg every other day) was initiated. After the second administration of cabergoline, the cat suffered from clinical hypoglycemia and no longer required insulin. One month after insulin withdrawal, blood work and urine analysis results showed normoglycemia, a normal serum fructosamine concentration (244μmol/l) and normal urine analysis without glycosuria. Diabetic remission persisted until its death 7 months later. In addition, cabergoline treatment was associated with improvement in clinical signs such as lethargy, seborrhea, alopecia and abdominal distension. Fil: Miceli, Diego Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Biología y Medicina Experimental. Fundación de Instituto de Biología y Medicina Experimental. Instituto de Biología y Medicina Experimental; Argentina. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; Argentina. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina Fil: Zelarayán, Gabriela S. Veterinaria Paraná; Argentina Fil: García, Jorge D. Universidad de Buenos Aires. Facultad de Ciencias Veterinarias. Hospital Escuela; Argentina Fil: Fernández, Viviana. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina Fil: Ferraris, Sergio. Universidad Maimónides. Centro de Ciencias Veterinarias; Argentina |
description |
A 7-year-old spayed female domestic shorthair cat weighing 5kg was referred with polyuria, polydipsia, lethargy, abdominal distension and dermatologic abnormalities. Diabetes mellitus was diagnosed and treatment was started with a diet for diabetic cats and insulin glargine (1IU q12h SC). Hyperadrenocorticism (HAC) was suspected and diagnosed based on clinical signs, increased urinary cortisol:creatinine ratio, lack of suppression on low-dose dexamethasone suppression test and abdominal ultrasonography demonstrating bilateral adrenal enlargement. Oral cabergoline (10μg/kg every other day) was initiated. After the second administration of cabergoline, the cat suffered from clinical hypoglycemia and no longer required insulin. One month after insulin withdrawal, blood work and urine analysis results showed normoglycemia, a normal serum fructosamine concentration (244μmol/l) and normal urine analysis without glycosuria. Diabetic remission persisted until its death 7 months later. In addition, cabergoline treatment was associated with improvement in clinical signs such as lethargy, seborrhea, alopecia and abdominal distension. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/140791 Miceli, Diego Daniel; Zelarayán, Gabriela S; García, Jorge D; Fernández, Viviana; Ferraris, Sergio; Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment; SAGE Publications; Journal of Feline Medicine and Surgery Open Reports; 7; 2; 6-2021; 1-7 2055-1169 2055-1169 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/140791 |
identifier_str_mv |
Miceli, Diego Daniel; Zelarayán, Gabriela S; García, Jorge D; Fernández, Viviana; Ferraris, Sergio; Diabetes mellitus remission in a cat with hyperadrenocorticism after cabergoline treatment; SAGE Publications; Journal of Feline Medicine and Surgery Open Reports; 7; 2; 6-2021; 1-7 2055-1169 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/http://journals.sagepub.com/doi/10.1177/20551169211029896 info:eu-repo/semantics/altIdentifier/doi/10.1177/20551169211029896 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
SAGE Publications |
publisher.none.fl_str_mv |
SAGE Publications |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269225017671680 |
score |
13.13397 |